GLTO logo

Galecto, Inc. (GLTO)

Profile

Full Name

Galecto, Inc.

Ticker

NASDAQ: GLTO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Denmark

IPO

October 29, 2020

Indexes

Not included

Website

https://galecto.com

Employees

5

Key Details

Price

$3.09(+2.66%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$18.53(+48.53% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.09
    GLTO price is $3.09

    30-Day Relative Volume

    24.48
    GLTO 30-day relative volume is 24.48

    Price Performance

    Price Most recent change

    +2.66%
    GLTO price was up +2.66% on Sep 8, 2025

    Price YTD change

    -33.55%
    GLTO price is down -33.55% since January 1st

    Price 1-year change

    -72.97%
    GLTO price is down -72.97% year-on-year

    Price 3-year change

    -95.25%
    GLTO price is down -95.25% over the past 3 years

    Price Range

    Price All-time high

    $449.75
    GLTO price is currently -99.31% below its historical high of $449.75

    Price 3-year low

    $2.01
    GLTO price is currently +53.73% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $4.09M
    GLTO market capitalization is $4.09 million

    Market cap 3-year change

    -93.8%
    GLTO market capitalization is down -93.8% over the past 3 years

    Market cap All-time high

    $414.01M
    GLTO market capitalization is currently -99.01% below its historical high of $414.01 million

    Market cap sector rank

    8.4%
    GLTO market capitalization is higher than 8.4% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +22.06%
    GLTO shares outstanding is up +22.06% year-on-year

    Shares Outstanding 3-Year Change

    +30.4%
    GLTO shares outstanding is up +30.4% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.71
    GLTO beta is 1.71

    200-day SMA

    $3.95
    GLTO price is currently -21.81% below its 200-day simple moving average

    50-day SMA

    $3.41
    GLTO price is currently -9.29% below its 50-day simple moving average

    RSI

    39.35
    GLTO 14-day relative strength index is 39.35

    Volume

    24.48
    GLTO 30-day relative volume is 24.48

    ATR

    $0.17
    GLTO average true range is $0.17

    10-day Historical Volatility

    40.81%
    GLTO 10-day historical volatility is 40.81%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    GLTO annual revenue is $0.00

    Revenue Analysts estimate

    -
    GLTO annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    GLTO annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.79%
    GLTO annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$18.53
    GLTO annual earnings per share is -$18.53

    EPS Analysts estimate

    -
    GLTO annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    +48.53%
    GLTO annual earnings per share is up +48.53% year-on-year

    EPS Sector rank

    8.49%
    GLTO annual earnings per share is higher than 8.49% of companies in Healthcare sector

    Profit

    Gross profit

    -$181.00K
    GLTO annual gross profit is -$181.00 thousand

    Gross margin

    -
    GLTO annual gross profit margin value is unknown

    Operating profit

    -$21.29M
    GLTO annual operating income is -$21.29 million

    Operating margin

    -
    GLTO annual operating profit margin value is unknown

    Net income

    -$21.44M
    GLTO annual net profit is -$21.44 million

    Net margin

    -
    GLTO annual net profit margin value is unknown

    Expenses

    Total expenses

    $21.29M
    GLTO annual total expenses is $21.29 million

    Operating expenses

    $21.29M
    GLTO annual total operating expenses is $21.29 million

    Cost of goods sold

    $181.00K
    GLTO annual cost of goods sold is $181.00 thousand

    Selling, general & administrative expenses

    $10.50M
    GLTO annual SGA is $10.50 million

    Depreciation and amortization

    $181.00K
    GLTO annual depreciation & amortization is $181.00 thousand

    Interest expense

    $0.00
    GLTO annual interest expense is $0.00

    Income tax

    $41.00K
    GLTO annual income tax is $41.00 thousand

    EBIT & EBITDA

    EBIT

    -$21.29M
    GLTO annual earnings before interest & taxes is -$21.29 million

    EBITDA

    -$21.11M
    GLTO annual EBITDA is -$21.11 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $17.13M
    GLTO annual total assets is $17.13 million

    Non current assets

    $293.00K
    GLTO annual long term assets is $293.00 thousand

    Current assets

    $16.84M
    GLTO annual total current assets is $16.84 million

    Cash and cash equivalents

    $14.18M
    GLTO annual cash & cash equivalents is $14.18 million

    Accounts receivable

    -
    GLTO annual accounts receivable value is unknown

    Inventory

    $0.00
    GLTO annual inventory is $0.00

    Liabilities

    Total liabilities

    $2.66M
    GLTO annual total liabilities is $2.66 million

    Long term liabilities

    $104.00K
    GLTO annual total long term liabilities is $104.00 thousand

    Current liabilities

    $1.20M
    GLTO annual total current liabilities is $1.20 million

    Accounts payable

    $377.00K
    GLTO annual accounts payable is $377.00 thousand

    Debt

    Total debt

    $1.43M
    GLTO annual total debt is $1.43 million

    Total debt 1-year change

    +475.5%
    GLTO annual total debt is up +475.5% year-on-year

    Long term debt

    $61.00K
    GLTO annual long term debt is $61.00 thousand

    Short term debt

    $12.00K
    GLTO annual short term debt is $12.00 thousand

    Equity & Capital

    Shareholders equity

    $14.47M
    GLTO annual stockholders equity is $14.47 million

    Book value

    $14.47M
    GLTO annual book value is $14.47 million

    Retained earnings

    -$277.52M
    GLTO annual retained earnings is -$277.52 million

    Working capital

    $15.64M
    GLTO annual working capital is $15.64 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$18.62M
    GLTO annual cash flow from operations is -$18.62 million

    Cash from operations 1-year change

    +49.55%
    GLTO annual cash flow from operations is up +49.55% year-on-year

    Cash from investing

    $11.65M
    GLTO annual cash flow from investing activities is $11.65 million

    Cash from investing 1-year change

    -47.83%
    GLTO annual cash flow from investing activities is down -47.83% year-on-year

    Cash from financing

    $0.00
    GLTO annual cash flow from financing activities is $0.00

    Cash from financing 1-year change

    -100%
    GLTO annual cash flow from financing activities is down -100% year-on-year

    CAPEX

    CAPEX

    $0.00
    GLTO annual capital expenditures is $0.00

    CAPEX 1-year change

    0%
    GLTO annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free cash flow

    -$18.62M
    GLTO annual free cash flow is -$18.62 million

    Free cash flow 1-year change

    +49.55%
    GLTO annual free cash flow is up +49.55% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    GLTO annual gross profit margin value is unknown

    Operating margin

    -
    GLTO annual operating profit margin value is unknown

    Net margin

    -
    GLTO annual net profit margin value is unknown

    ROA & ROE

    ROA

    -77.45%
    GLTO annual return on assets is -77.45%

    ROE

    -91.62%
    GLTO annual return on equity is -91.62%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    GLTO price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    GLTO price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.43
    GLTO price to book ratio is 0.43

    PB ratio Sector rank

    23.06%
    GLTO price to book ratio is higher than 23.06% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    GLTO price to sales ratio value is unknown

    PS ratio Sector rank

    -
    GLTO price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -$4.70M
    GLTO enterprise value is -$4.70 million

    Enterprise value Sector rank

    7.09%
    GLTO enterprise value is higher than 7.09% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.28
    GLTO EV/EBITDA is 0.28

    EV/EBITDA Sector rank

    69.59%
    GLTO EV/EBITDA is higher than 69.59% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    14.07
    GLTO annual current ratio is 14.07

    Quick ratio

    14.07
    GLTO annual quick ratio is 14.07

    Leverage

    Debt to equity

    0.10
    GLTO annual debt to equity ratio is 0.10

    Interest coverage ratio

    -
    GLTO annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    GLTO piotroski f-score value is unknown

    Altman Z-Score

    -24.76
    GLTO altman z-score is -24.76

    Analyst ratings

    Recent major analysts updates

    Oct 17, 24 Oppenheimer
    Outperform
    Jun 10, 24 Oppenheimer
    Outperform
    Sep 28, 23 HC Wainwright & Co.
    Neutral
    Aug 21, 23 HC Wainwright & Co.
    Buy
    Aug 15, 23 SVB Leerink
    Market Perform
    Aug 1, 23 Oppenheimer
    Outperform
    Aug 1, 23 HC Wainwright & Co.
    Buy
    Jun 20, 23 Oppenheimer
    Outperform
    May 24, 23 HC Wainwright & Co.
    Buy
    May 15, 23 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with GLTO included

    Growing Shares Outstanding
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    Ex Dividend dates calendar
    • What is the ticker symbol for Galecto, Inc.?
    • Does Galecto, Inc. pay dividends?
    • What sector is Galecto, Inc. in?
    • What industry is Galecto, Inc. in?
    • What country is Galecto, Inc. based in?
    • When did Galecto, Inc. go public?
    • Is Galecto, Inc. in the S&P 500?
    • Is Galecto, Inc. in the NASDAQ 100?
    • Is Galecto, Inc. in the Dow Jones?
    • When was Galecto, Inc.'s last earnings report?
    • When does Galecto, Inc. report earnings?

    What is the ticker symbol for Galecto, Inc.?

    The ticker symbol for Galecto, Inc. is NASDAQ:GLTO

    Does Galecto, Inc. pay dividends?

    No, Galecto, Inc. does not pay dividends

    What sector is Galecto, Inc. in?

    Galecto, Inc. is in the Healthcare sector

    What industry is Galecto, Inc. in?

    Galecto, Inc. is in the Biotechnology industry

    What country is Galecto, Inc. based in?

    Galecto, Inc. is headquartered in Denmark

    When did Galecto, Inc. go public?

    Galecto, Inc.'s initial public offering (IPO) was on October 29, 2020

    Is Galecto, Inc. in the S&P 500?

    No, Galecto, Inc. is not included in the S&P 500 index

    Is Galecto, Inc. in the NASDAQ 100?

    No, Galecto, Inc. is not included in the NASDAQ 100 index

    Is Galecto, Inc. in the Dow Jones?

    No, Galecto, Inc. is not included in the Dow Jones index

    When was Galecto, Inc.'s last earnings report?

    Galecto, Inc.'s most recent earnings report was on August 11, 2025

    When does Galecto, Inc. report earnings?

    The date for Galecto, Inc.'s next earnings report has not been announced yet
    On this page